RYTM

Rhythm Pharmaceuticals Inc.

Price

$115.73

return (12m)

19.08%

p/e

-38.90

p/bv

36.76

DIVIDEND YIELD

0.00%

RYTM price

Rhythm Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RYTM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.92%

3 months

28.32%

1 year

19.08%

2 years

145.71%

5 years

828.81%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals RYTM

Valuation

P/E

-38.90

Sector -4.38

Industry -4.38

P/BV

36.76

Sector 2.02

Industry 2.02

P/Revenue (PSR)

33.30

Sector -4.40

Industry -4.40

EV/EBITDA

-173.80

Sector -263.09

Industry -263.09

EV/EBIT

-172.82

Sector -702.90

Industry -702.90

P/EBITDA

-43.25

Sector -4.39

Industry -4.39

P/EBIT

-43.00

Sector -4.73

Industry -4.73

P/Total Assets

18.27

Sector 1.49

Industry 1.49

P/Net Current Assets

38.67

Sector -11.70

Industry -11.70

P/Working Capital

26.37

Sector -3.19

Industry -3.19

EPS

-2.98

Sector -2.14

Industry -2.14

BVPS

3.15

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

89.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-61.84%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-62.19%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-83.62%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-85.59%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.16

Sector 0.03

Industry 0.03

Profitability

ROE

-94.50%

Sector -65.14%

Industry -65.14%

ROA

-46.96%

Sector -65.53%

Industry -65.53%

ROIC

-651.18%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.45

Sector 2.90

Industry 2.90

Net Debt / EBITDA

7.51

Sector -6.07

Industry -6.07

Net Debt / EBIT

7.47

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.52

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.50

Sector 0.41

Industry 0.41

Liabilities/Assets

0.50

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

137.72%

Sector -

Industry -

5Y Earnings CAGR

24.15%

Sector -

Industry -

Fundamentals RYTM

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RYTM Rhythm Pharmaceuticals Inc.	$115.73	17.98%	0.00%	-38.90	36.76	-94.50%	-85.59%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RYTM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (2 people)

United States

18 years

Founded: 2008

2017

Time since IPO - 9 years

90

Employees

Rhythm Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.99 billion, with shareholders equity totaling $217.30 million.

The company employs approximately 90 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Rhythm Pharmaceuticals Inc. reported $239.91 million in revenue, generating net income of $-205.35 million.

Key financial metrics include a P/E ratio of -38.90, a price-to-book (P/B) ratio of 36.76, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RYTM.

Market cap

$7.99 billion

Net worth

$217.30 million

$217,300,000.00

Assets

$437.27 million

$437,270,000.00

Total Shares Outstanding

69.00 million

69,000,000

Average Daily Trading Volume

$837.68 Thousand

$837,679.38

Sector

Health Care

Industry

Biotechnology

RYTM

RYTM revenue and profits

Financial Results RYTM

DRAG THE FRAME TO SEE MORE DATA

RYTM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Rhythm Pharmaceuticals (RYTM) today?

A cotação de Rhythm Pharmaceuticals (RYTM) hoje está em US$ 115.73, com uma variação de 19.08% em relação ao último ano. A cotação de Rhythm Pharmaceuticals (RYTM) iniciou o ano negociando na casa dos US$ 107.04 e hoje está em US$ 115.73. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Rhythm Pharmaceuticals (RYTM) e dados de ações do Ibovespa e mercados internacionais.

Quando Rhythm Pharmaceuticals (RYTM) paga dividendos?

Rhythm Pharmaceuticals (RYTM) não distribuiu dividendos no último ano.

Is Rhythm Pharmaceuticals (RYTM) a good investment?

Atualmente, Rhythm Pharmaceuticals (RYTM) está cotada a US$ 115.73, com um P/L de -38.90, representando um desvio de -2,222% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 19.08 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 19.08%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Rhythm Pharmaceuticals (RYTM) stock?

Investir em ações de Rhythm Pharmaceuticals (RYTM) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Rhythm Pharmaceuticals (RYTM) yield today?

A rentabilidade de Rhythm Pharmaceuticals (RYTM) foi de 8.92% no último mês, 19.08% no último ano e 828.81% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Rhythm Pharmaceuticals (RYTM) hoje, o investimento total seria de US$ 11,573.00, com base na cotação atual de US$ 115.73.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 13,781.13
Em 5 anos: US$ 107,491.18
Em 10 anos: US$ 11,573.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RYTM

Rhythm Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RYTM

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RYTM WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Inc.

United States

18 years

2017

90

PROFIT X PRICE RYTM

Financial Results RYTM

RYTM cash flow

Asset, Revenue and Profit Growth - RYTM

RYTM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions